Research is communicated more effectively and reproducibly when articles depict genetic designs consistently and fully disclose the complete sequences of all reported constructs. ACS Synthetic Biology is now providing authors with updated guidance and piloting a new tool and publication workflow that facilitate compliance with these recommended practices and standards for visual representation and data exchange. I n every scientific and engineering discipline, communication about research and development is made more effective by the adoption of community standards.
I
n every scientific and engineering discipline, communication about research and development is made more effective by the adoption of community standards. 1 For synthetic biology, it has previously been suggested that research articles should consistently depict genetic designs 2, 3 and fully disclose the complete sequences of all the constructs they describe. 4−6 To this end, ACS Synthetic Biology editorial policy 7 has, from its beginning, stated that authors should deposit their reported organisms and sequence data into established public repositories (where possible) or in Supporting Information. ACS Synthetic Biology is now providing authors with updated guidance along with new tools that make it easier for authors to follow these recommended practices, using community-developed standards for visual representation 2, 3 and data exchange, 8−10 along with digital and physical repositories.
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■ VISUAL REPRESENTATION OF GENETIC DESIGNS
People engineering biological organisms often need to communicate in diagrams, both about the structure of nucleic acid sequences and about the functional relationships of nucleic acid sequences, their components, and other biological substances. Standardized languages for such diagrams can improve communication by decreasing ambiguity and increasing the amount of information that can be conveyed without accompanying explanation. At the same time, languages are more widely applicable when they allow as much flexibility and freedom as possible in how diagrams are organized, presented, and styled, either by hand or with the aid of various software programs.
For these reasons, ACS Synthetic Biology now recommends that authors visually depict genetic designs in their manuscript figures using the Synthetic Biology Open Language (SBOL) Visual standard 2,3 whenever applicable. SBOL Visual codifies and refines what are already fairly common practices in the representation of genetic sequence designs, in which glyphs representing sequence features are attached to lines representing nucleic acid backbone (Figure 1 ). Use of SBOL Visual will not inhibit the stylistic choices of authors, as it imposes no constraints on color, text, scaling, etc. The main effect of adopting SBOL Visual is that certain glyphs are now given formal definitions and must only be used to represent sequence features with those types, e.g., authors may not arbitrarily choose that in their diagrams the "bent arrow" commonly used to represent a promoter will instead mean a terminator. For any type of sequence feature or glyph not specifically defined by SBOL Visual, however, authors are as always encouraged to create the clearest imagery they can to represent it, and to submit their new glyphs to be considered for adoption into SBOL Visual. Full information about SBOL Visual, including a On the basis of recent advancements in both representation format and available repositories, ACS Synthetic Biology now recommends that all authors digitally deposit their genetic designs using the Synthetic Biology Open Language (SBOL) data exchange format. 8, 9 Full information about SBOL can be found at http://sbolstandard.org. In particular, it is recommended that authors use SBOL version 2.0 or above, as this allows representation of not only sequence and sequence features, but also the expected functional interactions between design elements.
Authors may benefit from using a variety of community software tools 16 when preparing genetic design figures and digital files. One tool in particular for authors to consider when preparing their genetic design files is the SBOL Validator/ Converter tool, 17 that will validate that a given file complies with the SBOL 2 data exchange standard as well as convert other file formats (e.g., Genbank, FASTA, SBOL 1) to SBOL 2.
■ WORKFLOW FOR GENETIC DESIGN DEPOSIT AND REVIEW
In order to simplify sharing of genetic design information for both authors, editors, and reviewers, ACS Synthetic Biology has instantiated a digital registry of genetic designs and microbial strains at https://acs-registry.jbei.org. Authors are encouraged to use this registry to deposit their sequence and design information, as well as organism information, during the manuscript submission process.
Authors using the ACS Synthetic Biology Registry will follow the following steps:
1 19 ) that may be useful during the figure preparation process.
Once an author using the ACS Synthetic Biology Registry has submitted a manuscript for publication (it is crucial that a link to the collection of entries in the ACS Synthetic Biology Registry be included in the Supporting Information), ACS Synthetic Biology editorial staff will generate a zip file that contains a validated SBOL 2 (as well as a Genbank) format file for each reported DNA sequence, in addition to a comma-separated value (CSV) spreadsheet file that lists additional information associated with each of the reported strains and DNA sequences. This zip file will then be uploaded as additional Supporting Information for the manuscript, which reviewers will have access to during the review process. Once the manuscript is published, the ACS Synthetic Biology editorial staff will set the manuscript's collection to public, so that anyone with an ACS Synthetic Biology Registry account (or with an account on another registry connected via Web of Registries functionality, Plahar et al., unpublished) will have informatic access to all of the reported strains and DNA sequences. Should the manuscript not be published, however, the manuscript's collection and associated strain and DNA sequence entries will remain private to the author.
■ FUTURE DIRECTIONS
Community standards and practices are not static, but may be expected to continue evolving over time, as the needs and knowledge of the community evolves. The adoption of these standards by ACS Synthetic Biology and the use of the registry workflow we describe is at the moment in its pilot phase, and compliance with SBOL Visual and SBOL 2 data standards will (for the moment at least) remain a voluntary opt-in recommended practice, and not an editorial mandate. Manuscripts that do follow these standards, however, will be marked with symbols indicating that they follow community standards for diagrams, data representation, and sharing of data in an approved public repository (such as the ACS Synthetic Biology Registry).
We expect that both the above-described workflow and the standards that support it will be continually improved over time.
The standards are open community efforts to which all practitioners are encouraged to contribute, in order to ensure they best serve the needs of the greatest number of synthetic biologists. For the workflow, it is anticipated that it will in the future expand to also incorporate other community repositories that provide the same functionality prerequisites (i.e., stable public access for the community, SBOL 2.0+ data-exchange, granular authentication/authorization access controls, URL addressable collections of entries, Web of Registries integration, and editor tools for collection generation and publication). Future workflows may also integrate reviewing more directly with repositories, so that reviewers can benefit from repository tools for exploration and visualization of design collections.
It is hoped that these new recommendations for authors and the availability of the new ACS Synthetic Biology Registry will add value to the manuscript publications process for authors, reviewers, editors, and the broader scientific community alike. Feedback from the community will contribute to the continual improvement of the synthetic biology publishing process.
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